GO:0006542 obsolete glutamine biosynthetic process

GO:0006542, obsolete glutamine biosynthetic process, was a Gene Ontology biological process term that described the chemical reactions and pathways resulting in the formation of glutamine, 2-amino-4-carbamoylbutanoic acid. Although the term is now obsolete, its underlying biology remains a cornerstone of nitrogen metabolism, and researchers continue to study glutamine synthesis in contexts ranging from cancer cell proliferation to hepatic encephalopathy. The process is essential for maintaining cellular nitrogen balance and providing precursors for nucleotides, amino sugars, and glutathione. In pathophysiological states, altered amino acid adequacy, including glutamine availability, can influence clinical outcomes in conditions such as sepsis, trauma, and chronic liver disease. Understanding the historical GO term and its associated genes helps researchers navigate legacy annotations and design modern experiments that target glutamine metabolism. This article synthesizes the QuickGO definition with real PubMed literature to provide a research-grade overview of the obsolete term, its key genes, regulatory mechanisms, disease links, and experimental models.

According to the QuickGO definition, GO:0006542 (obsolete glutamine biosynthetic process) referred to the chemical reactions and pathways resulting in the formation of glutamine, 2-amino-4-carbamoylbutanoic acid. The term was classified under biological_process and carried synonyms including glutamine anabolism, glutamine biosynthesis, glutamine formation, and glutamine synthesis. Because the term has been marked obsolete, it is no longer recommended for annotation; however, its definition remains useful for understanding historical datasets and for mapping legacy gene sets to current GO terms.

Although GO:0006542 is obsolete, the biological process it described remains critically important because glutamine is the most abundant free amino acid in the body and serves as a nitrogen donor for nucleotide and amino sugar synthesis, a substrate for glutathione production, and a key fuel for rapidly proliferating cells. In cancer, glutamine metabolism supports the metabolic demands of tumor cells and contributes to resistance to chemotherapy, as shown in liver cancer models where the HGF-MET axis coordinates metabolism and autophagy. In pathophysiological states such as sepsis, trauma, and liver disease, amino acid adequacy including glutamine availability can affect protein synthesis and clinical outcomes. Therefore, studying the genes and pathways historically annotated under this term provides insight into metabolic reprogramming and identifies potential therapeutic targets.

The following genes and proteins have been historically associated with glutamine biosynthesis and related metabolic pathways, based on published literature.

Glutamine biosynthesis is regulated at multiple levels, including transcriptional control of GLUL, allosteric regulation by metabolites, and signaling through the HGF-MET axis. In liver cancer, HGF-MET signaling coordinates glutamine metabolism with autophagy to promote chemotherapeutic resistance, indicating that this pathway is responsive to microenvironmental cues. Amino acid adequacy, including glutamine availability, is also influenced by systemic factors in pathophysiological states such as sepsis and trauma. Additionally, mTORC1 signaling is sensitive to glutamine levels, linking glutamine synthesis to cell growth control.

Glutamine biosynthesis supports the metabolic demands of cancer cells, and its dysregulation is linked to chemotherapeutic resistance. In liver cancer, the HGF-MET axis coordinates glutamine metabolism and autophagy, enabling tumor cells to survive chemotherapy. Targeting glutamine synthesis enzymes such as GLUL may therefore sensitize tumors to treatment.

Alterations in amino acid adequacy, including glutamine, are observed in pathophysiological states such as sepsis, trauma, and chronic liver disease. These changes can affect protein synthesis, immune function, and clinical outcomes, highlighting the importance of understanding glutamine metabolism in systemic disease.

Glutamine synthesis in the brain and liver is critical for ammonia detoxification and neurotransmitter cycling. Dysregulation of GLUL has been implicated in hepatic encephalopathy and other neurological conditions, although the obsolete GO term itself is no longer used for annotation.

Stable isotope tracing with 13C/15N-labeled glutamine or glutamate can quantify flux through glutamine synthesis and related pathways. This method is particularly useful for studying cancer metabolism and the effects of HGF-MET signaling.

Genome-wide CRISPR knockout screens can identify genes required for glutamine independence or sensitivity, including GLUL and transporters. Such screens have revealed metabolic vulnerabilities in liver cancer models.

Autophagy flux assays combined with chemotherapy treatment can determine how glutamine metabolism contributes to drug resistance. The HGF-MET axis has been shown to coordinate these processes in liver cancer.

Quantitative amino acid analysis by mass spectrometry can assess glutamine and glutamate levels in cells and tissues, providing insights into pathophysiological states.

Researchers studying obsolete glutamine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolic reprogramming, chemoresistance, or amino acid adequacy disorders. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.

GO:0006542, obsolete glutamine biosynthetic process, remains a valuable historical concept for understanding glutamine metabolism, even though it is no longer an active GO term. The underlying biology, centered on enzymes like GLUL and pathways linked to the HGF-MET axis, is critical in cancer metabolism, chemoresistance, and amino acid adequacy disorders. Modern CRISPR-based models enable precise interrogation of these pathways, and EDITGENE offers comprehensive services to support such research.